Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial - Srivastava, A; Rangarajan, S; Kavakli, K (Lancet Haematol, 2023)